Potential Strategies to Reduce Blood Pressure in Treatment-Resistant Hypertension Using Food and Drug Administration–Approved Nanodrug Delivery Platforms
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Strategies to Reduce Blood Pressure in Treatment-Resistant Hypertension Using Food and Drug Administration–Approved Nanodrug Delivery Platforms
Authors
Keywords
-
Journal
HYPERTENSION
Volume 73, Issue 2, Pages 250-257
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-01-10
DOI
10.1161/hypertensionaha.118.12005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulatory challenges of nanomedicines and their follow-on versions: A generic or similar approach?
- (2018) Stefan Mühlebach ADVANCED DRUG DELIVERY REVIEWS
- Polylactic Acid/Chitosan Nanoparticles Loading Nifedipine: Characterization Findings and In Vivo Investigation in Animal
- (2018) Nguyen Thuy Chinh et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery
- (2018) Narottam Lamichhane et al. MOLECULES
- Diagnosis and management of resistant hypertension: state of the art
- (2018) Fang-Fei Wei et al. Nature Reviews Nephrology
- Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
- (2018) Susan Hua et al. Frontiers in Pharmacology
- Enhanced physicochemical stability and efficacy of angiotensin I-converting enzyme (ACE) - inhibitory biopeptides by chitosan nanoparticles optimized using Box-Behnken design
- (2018) Shehu Muhammad Auwal et al. Scientific Reports
- Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension
- (2017) Victor Segura-Ibarra et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Progress in brain targeting drug delivery system by nasal route
- (2017) Abdur Rauf Khan et al. JOURNAL OF CONTROLLED RELEASE
- Oxidative Stress and Hypertensive Diseases
- (2017) Roxana Loperena et al. MEDICAL CLINICS OF NORTH AMERICA
- Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials
- (2016) Henry A. Havel AAPS Journal
- Antihypertensive nano-ceuticales based on chitosan biopolymer: Physico-chemical evaluation and release kinetics
- (2016) Taskeen Niaz et al. CARBOHYDRATE POLYMERS
- Inclusion complexes of hydrochlorothiazide and β-cyclodextrin: Physicochemical characteristics, in vitro and in vivo studies
- (2016) Cassiana Mendes et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis
- (2016) Denise Oró et al. JOURNAL OF HEPATOLOGY
- A novel nanoproliposomes of lercanidipine: Development, in vitro and preclinical studies to support its effectiveness in hypertension therapy
- (2016) Praful Balavant Deshpande et al. LIFE SCIENCES
- Emerging nanomedicine applications and manufacturing: progress and challenges
- (2016) Felicity Sartain et al. Nanomedicine
- Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
- (2016) Daniel Bobo et al. PHARMACEUTICAL RESEARCH
- AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus
- (2015) Esther S. Kim et al. DRUGS
- Efficacy of the superoxide dismutase mimetic tempol in animal hypertension models
- (2015) Waleska C. Dornas et al. JOURNAL OF HYPERTENSION
- Magnetic poly(d,l-lactide) nanoparticles loaded with aliskiren: A promising tool for hypertension treatment
- (2015) Iryna Antal et al. JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
- PEGylated Liposomes as Carriers of Hydrophobic Porphyrins
- (2015) Monika Dzieciuch et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Development of Sustained Release “NanoFDC (Fixed Dose Combination)” for Hypertension – An Experimental Study
- (2015) Anjuman Arora et al. PLoS One
- Systematic Review and Meta-Analysis of the Prevalence of Resistant Hypertension in Treated Hypertensive Populations
- (2014) Dmitrij Achelrod et al. AMERICAN JOURNAL OF HYPERTENSION
- A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications
- (2014) Jaya Raju Lakkakula et al. Nanomedicine
- Rapamycin Ameliorates Inflammation and Fibrosis in the Early Phase of Cirrhotic Portal Hypertension in Rats through Inhibition of mTORC1 but Not mTORC2
- (2014) Weijie Wang et al. PLoS One
- Improvement in antihypertensive and antianginal effects of felodipine by enhanced absorption from PLGA nanoparticles optimized by factorial design
- (2013) Umang Shah et al. Materials Science & Engineering C-Materials for Biological Applications
- Cerium oxide nanoparticles: applications and prospects in nanomedicine
- (2013) Soumen Das et al. Nanomedicine
- PLGA-based nanoparticles: An overview of biomedical applications
- (2012) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs
- (2012) Lei Gao et al. PHARMACEUTICAL RESEARCH
- Clinical Potential of VIP by Modified Pharmaco-kinetics and Delivery Mechanisms
- (2012) Bernhard Burian et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Nanoparticles Targeting the Infarcted Heart
- (2011) Tal Dvir et al. NANO LETTERS
- Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan
- (2011) Abdul Ahad et al. Nanomedicine-Nanotechnology Biology and Medicine
- Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
- (2010) Katrin Knop et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Drug Therapy for Resistant Hypertension: Simplifying the Approach
- (2010) Samuel J. Mann Journal of Clinical Hypertension
- Pharmaceutical Composition of Valsartan: β-Cyclodextrin: Physico–Chemical Characterization and Anti-Hypertensive Evaluation
- (2010) Carlos Eduardo De Matos Jensen et al. MOLECULES
- Polymer-based nanocapsules for drug delivery
- (2009) C.E. Mora-Huertas et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Rapamycin prevents mesenteric neo-angiogenesis and reduces splanchnic blood flow in portal hypertensive mice
- (2008) Anja M. Geerts et al. HEPATOLOGY RESEARCH
- Inhalable liposomal formulation for vasoactive intestinal peptide
- (2008) Franz Hajos et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Increased Biological Half-Life of Aerosolized Liposomal Recombinant Human Cu/Zn Superoxide Dismutase in Pigs
- (2008) Martin Kaipel et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Oral Nanoparticulate Atorvastatin Calcium is More Efficient and Safe in Comparison to Lipicure® in Treating Hyperlipidemia
- (2008) A. K. Meena et al. LIPIDS
- PLGA Nanoparticles for Oral Delivery of Hydrophobic Drugs: Influence of Organic Solvent on Nanoparticle Formation and Release Behavior In Vitro and In Vivo Using Estradiol as a Model Drug
- (2007) D.K. Sahana et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started